Erlocip Tablet is available in two types:
Erlocip 150- 30 Tablet or Erlocip 100- 30 Tablet is an anti-cancer cancer medicine used in the treatment of small-cell lung cancer and pancreatic cancer in men. It contains the drug Erlotinib, which belongs to a group of medicines called Cytostatic agents. If your disease remains unchanged after initial chemotherapy. This medicine is prescribed to you either as initial therapy or as an alternative therapy.
Erlotinib is an inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase that is used in the treatment of small-cell lung cancer and pancreatic cancer.
Small-cell lung cancer
Small-cell lung cancer is fast-growing lung cancer that develops in the tissues of the lungs. This has spread outside the lungs. This cancer is more likely than other types of lung cancer. It comes back after treatment. Small cell lung cancer is oval-shaped cells that look like oat grains.
Pancreatic cancer begins in the tissues of the pancreas- an organ in your abdomen that lies in the lower part of the stomach. Several types of growth occur in the pancreas including cancerous and non-cancerous cells. The most common type of cancer that forms in the pancreas carries digestive enzymes out of the pancreas.
Sometimes it is detected at an early stage.
Erlocip 150 and Erlocip 100 mg can be taken with or without a meal. It should take 1 hour before and 2 hours after a meal at a fixed time every day. Before taking medicine consult your doctor. The dose and duration of both medicines will be decided by necessity and need of the patient.
It depends on the treatment and may change from time to time. You should take medicine as per your doctor’s advice. These medicines are strictly not recommended for pregnant women, children, and breastfeeding women.
Common side effects of Erlocip 100-30 Tablet include nausea, vomiting, fatigue, rash, and weight loss. It can cause severe diarrhea. Drink plenty of water. Consult with your doctor. It makes your skin sensitive therefore wear proper cloth and use sunscreen while going outside. It is better to inform your doctor to prevent side effects
Common side effects of Erlocip 150-30 Tablet include nausea, vomiting, rash, fatigue, and weight loss. Protect from sunlight. Change in vision, ulcer in the mouth.
It is better to inform your doctor. The dose and duration of both the medicine will depend on the patient’s medical condition. Need high and low dose depends on the patient’s condition.
Benefit of Erlocip 150 mg 100-30 Tablet and Erlocip 100 mg 100-30 Tablet
Non-small-cell lung cancer
Nonsmall-cell lung cancer is a cancer of the lung. Erlocip 150 mg or Erlocip 100 mg both help in the treatment of lung cancer. It may be given alone or in combination with other medicines. It is a very powerful medicine so discuss its risks and benefits with your doctor. Dose and frequency are dependent on patient needs.
The pancreas is essential for the digestive system and it helps in maintaining blood sugar level that produces the body’s natural insulin. Both medicines help to control pancreatic cancer. It will relieve symptoms like vomiting, weight loss, and lack of appetite. Eroclip 150 mg and Eroclip 100 mg both help to stop the action of chemicals that help in the growth and spread of cancer cells. It gives you relief and healthier life. Dose of medicine as per patient’s requirement.
Side effects of Eroclip 150 mg
- Burning sensation
- Lower back
- Side back
- Chest pain
- Stomach pain
- Hair loss
Side effects of Eroclip 100 mg
- Abdominal pain
- Bone pain
How to take Eroclip 150 or Eroclip 100 mg?
Always take the medicine as per your doctor’s consultation. Take it with or without food. Dose and duration will decide according to a patient’s health condition. Do not chew, crush and break the medicine.
Take this medicine every day at the time prescribed by the doctor. Many other medicines can affect this medicine so let your doctor know the medication you are using during treatment.
How does Eroclip 150 mg and Eroclip 100 mg work?
It is an anti-cancer medicine. This medicine works by blocking the chemicals and stopping the cancer signal. EFGR is expressed on the surface of both normal and cancer cells. Inhibition of EGFR decreases tumor growth and its survival. It restricts the further growth of cancer.